Last year's Fierce 15 med tech winners include an implant maker for sinusitis that recently filed for an $80 million IPO, a fierce competitor to device giants Medtronic ($MDT) and Edwards Lifesciences ($EW) in the emerging market for minimally invasive heart valves and a market leader in developing nerve-stimulating implant for rheumatoid arthritis and Crohn's disease.
What will 2014 bring? That depends on you.
We are now accepting nominations for the most promising emerging med tech companies of 2014. Fill out the form to ensure your favorite company gets its due consideration. Given the myriad advancements in science and technology this year, picking just 15 companies is a daunting task. Please make the selection process easier (or more difficult, as the case may be) by suggesting winners and offering compelling justifications.
As always, the nominees should meet the following critera:
- Companies must be privately held, not publicly traded.
- Companies should be working on treatments for human diseases. This is not a list of agricultural bio or biofuel ventures.
- Company executives must be available for interviews and agree to keep their status in our selection process confidential until the final list is announced.
And that it's. We take an open-ended approach. Diagnostics companies and international or emerging markets contenders are welcomed. The deadline for submission is August 15.
Thank you for your time. The winners will be announced in October. -- Varun Saxena (email | Twitter)
This year's FierceMedicalDevices Fierce 15 is brought to you by Novella Clinical.